| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |